TipRanks
Regencell Bioscience (RGC)
NASDAQ:RGC
US Market
RGC
Regencell Bioscience
RESEARCH TOOLSreports

Regencell Bioscience (RGC) Ratios

625 Followers

Regencell Bioscience Ratios

RGC's free cash flow for Q4 2026 was $0.00. For the 2026 fiscal year, RGC's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Jun 26Jun 25Jun 24Jun 23
Liquidity Ratios
Current Ratio
 10.77 10.77 7.39 41.92 19.15
Quick Ratio
 10.77 10.77 7.39 41.92 19.24
Cash Ratio
 10.75 10.75 3.65 15.30 2.58
Solvency Ratio
 -8.19 -8.19 -3.56 -16.20 -8.07
Operating Cash Flow Ratio
 -5.83 -5.83 -4.69 -20.67 -8.18
Short-Term Operating Cash Flow Coverage
 -32.57 -32.57 -9.95 0.00 0.00
Net Current Asset Value
$ 12.84M$ 12.84M$ 4.01M$ 7.89M$ 10.99M
Leverage Ratios
Debt-to-Assets Ratio
 0.02 0.02 0.09 0.01 0.04
Debt-to-Equity Ratio
 0.02 0.02 0.11 0.01 0.04
Debt-to-Capital Ratio
 0.02 0.02 0.10 0.01 0.04
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.10 1.10 1.18 1.03 1.05
Debt Service Coverage Ratio
 -47.90 -47.90 -10.20 0.00 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 <0.01 <0.01 <0.01 0.00 0.00
Interest Debt Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
 1.23 1.23 0.59 0.79 0.21
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%0.00%
EBIT Margin
0.00%0.00%0.00%0.00%0.00%
EBITDA Margin
0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin
0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Profit Margin
0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT
100.00%100.00%100.00%98.59%96.85%
EBT Per EBIT
99.81%99.81%95.07%92.11%96.63%
Return on Assets (ROA)
-79.45%-79.45%-62.27%-50.98%-46.52%
Return on Equity (ROE)
-160.64%-87.66%-73.75%-52.34%-48.80%
Return on Capital Employed (ROCE)
-87.44%-87.44%-74.04%-57.45%-52.22%
Return on Invested Capital (ROIC)
-85.92%-85.92%-69.75%-57.04%-50.38%
Return on Tangible Assets
-79.45%-79.45%-62.27%-50.98%-46.52%
Earnings Yield
-0.32%-0.39%-0.04%-0.01%-0.02%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00 0.00
Payables Turnover
 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 -13.61
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle
 0.00 0.00 0.00 0.00 -26.82
Days of Sales Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 -26.82
Days of Payables Outstanding
 0.00 0.00 0.00 0.00 0.00
Operating Cycle
 0.00 0.00 0.00 0.00 -26.82
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.02 -0.02 >-0.01 >-0.01 -0.01
Free Cash Flow Per Share
 -0.02 -0.02 >-0.01 >-0.01 -0.01
CapEx Per Share
 <0.01 0.00 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.05 1.00 1.01
Dividend Paid and CapEx Coverage Ratio
 -3.85M 0.00 -20.39 -744.36 -181.18
Capital Expenditure Coverage Ratio
 -3.85M 0.00 -20.39 -744.36 -181.18
Operating Cash Flow Coverage Ratio
 -26.02 -26.02 -5.72 -46.67 -10.70
Operating Cash Flow to Sales Ratio
 0.00 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-0.21%-0.26%-0.04%-0.01%-0.02%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -311.44 -256.96 -2.37K -6.90K -5.05K
Price-to-Sales (P/S) Ratio
 0.00 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 272.38 225.64 1.73K 3.61K 2.47K
Price-to-Free Cash Flow (P/FCF) Ratio
 -473.23 -391.41 -2.58K -7.40K -5.95K
Price-to-Operating Cash Flow Ratio
 -472.49 -391.41 -2.71K -7.41K -5.98K
Price-to-Earnings Growth (PEG) Ratio
 3.14 -1.12 137.27 256.48 244.52
Enterprise Value Multiple
 -320.48 -264.86 -2.64K -8.20K -5.61K
Enterprise Value
 3.63B 3.00B 8.42B 29.67B 29.67B
EV to EBITDA
 -320.48 -264.86 -2.64K -8.20K -5.61K
EV to Sales
 0.00 0.00 0.00 0.00 0.00
EV to Free Cash Flow
 -471.42 -389.61 -2.58K -7.40K -5.95K
EV to Operating Cash Flow
 -471.42 -389.61 -2.71K -7.41K -5.98K
Tangible Book Value Per Share
 0.03 0.03 <0.01 0.02 0.02
Shareholders’ Equity Per Share
 0.03 0.03 <0.01 0.02 0.02
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.00 0.00 0.00 0.00 0.00
Net Income Per Share
 -0.02 -0.02 >-0.01 >-0.01 -0.01
Tax Burden
 1.00 1.00 1.00 0.99 0.97
Interest Burden
 1.00 1.00 1.00 1.00 1.00
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.66 0.66 0.87 0.92 0.85
Currency in USD